CRISPINA CALSADA
CIK 1606833 · Chief Financial Officer · last filed 2025-06-27
CRISPINA CALSADA is a Chief Financial Officer who has filed 15 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing, for RGLS, was dated Jun 27, 2025. Across all open-market trades the lifetime net is −$61.8K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
15
-$61.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Regulus Therapeutics Inc. (RGLS) Delisted | Chief Financial Officer | 0 | $8.16 | $0 | -$61.8K | 15 | 2025-06-27 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-27 | Regulus Therapeutics Inc. (RGLS) Delisted | Disp (D) | −140,228 | $0 | EDGAR |
| 2025-01-31 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-15 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −43,804 | -$55.3K | EDGAR |
| 2025-01-10 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | +83,500 | $112.3K | EDGAR |
| 2024-05-21 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-18 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −5,468 | -$6.5K | EDGAR |
| 2024-01-17 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | +11,250 | $0 | EDGAR |
| 2023-08-14 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-17 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-11 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |